User profiles for Greg Matlashewski

Greg Matlashewski

McGill University
Verified email at mcgill.ca
Cited by 15954

Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer

…, F Mantovani, J Breuer, IM Leigh, G Matlashewski… - Nature, 1998 - nature.com
The E6 oncoprotein derived from tumour-associated human papillomaviruses (HPVs) binds
to and induces the degradation of the cellular tumour-suppressor protein p53. A common …

Two polymorphic variants of wild-type p53 differ biochemically and biologically

…, D Pim, L Banks, G Matlashewski - … and cellular biology, 1999 - Am Soc Microbiol
The wild-type p53 protein exhibits a common polymorphism at amino acid 72, resulting in
either a proline residue (p53 Pro) or an arginine residue (p53 Arg) at this position. Despite the …

Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.

G Matlashewski, P Lamb, D Pim, J Peacock… - The EMBO …, 1984 - embopress.org
A cDNA clone for human p53 cellular tumor antigen has been isolated and characterized.
This clone contains the complete 3′‐untranslated region and most of the open reading frame …

Intracellular infection by Leishmania donovani inhibits macrophage apoptosis.

KJ Moore, G Matlashewski - Journal of immunology (Baltimore, Md …, 1994 - journals.aai.org
The phagocytic macrophage plays a critical role in host immune responses to microbial
infection, and represents a major source of inflammatory and growth cytokines. Intramacrophage …

Regulation of human p53 activity and cell localization by alternative splicing

…, D Stewart, G Matlashewski - Molecular and cellular …, 2004 - Am Soc Microbiol
The development of cancer is a multistep process involving mutations in proto-oncogenes,
tumor suppressor genes, and other genes which control cell proliferation, telomere stability, …

Immune Responses Induced by the Leishmania (Leishmania) donovani A2 Antigen, but Not by the LACK Antigen, Are Protective against Experimental Leishmania (Leishmania …

…, RC Rodrigues, H Charest, G Matlashewski… - Infection and …, 2003 - Am Soc Microbiol
Leishmania amazonensis is one of the major etiologic agents of a broad spectrum of clinical
forms of leishmaniasis and has a wide geographical distribution in the Americas, which …

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator

…, E Najar, E Alvarez, G Matlashewski… - Clinical infectious …, 2001 - academic.oup.com
Abstract Treatment failures for leishmaniasis with pentavalent antimonials, including meglumine
antimonate, are increasingly common in many endemic areas. Imiquimod (Aldara; 3M …

Determinants for the development of visceral leishmaniasis disease

LI McCall, WW Zhang, G Matlashewski - PLoS pathogens, 2013 - journals.plos.org
Leishmaniasis is a vector-borne neglected tropical disease associated with a spectrum of
clinical manifestations, ranging from self-healing cutaneous lesions to fatal visceral infections. …

Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action

S Buates, G Matlashewski - The Journal of infectious diseases, 1999 - academic.oup.com
There is a need for new, effective, and less toxic treatments for leishmaniasis, an infectious
disease caused by Leishmania protozoa and is a major cause of suffering and morbidity in …

Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression

L BANKS, G MATLASHEWSKI… - European Journal of …, 1986 - Wiley Online Library
The isolation and construction of a complete human p53 cDNA and subsequent expression
in monkey cells is described. A set of new anti‐(human p53) monoclonal antibodies has also …